ID   ACK1_HUMAN              Reviewed;        1038 AA.
AC   Q07912; Q6ZMQ0; Q8N6U7; Q96H59;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   05-OCT-2010, entry version 113.
DE   RecName: Full=Activated CDC42 kinase 1;
DE            Short=ACK-1;
DE            EC=2.7.10.2;
DE   AltName: Full=Tyrosine kinase non-receptor protein 2;
GN   Name=TNK2; Synonyms=ACK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH CDC42.
RC   TISSUE=Hippocampus;
RX   MEDLINE=93268389; PubMed=8497321; DOI=10.1038/363364a0;
RA   Manser E., Leung T., Salihuddin H., Tan L., Lim L.;
RT   "A non-receptor tyrosine kinase that inhibits the GTPase activity of
RT   p21cdc42.";
RL   Nature 363:364-367(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   LEU-725.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH CSPG4.
RX   PubMed=10587647; DOI=10.1038/70302;
RA   Eisenmann K.M., McCarthy J.B., Simpson M.A., Keely P.J., Guan J.-L.,
RA   Tachibana K., Lim L., Manser E., Furcht L.T., Iida J.;
RT   "Melanoma chondroitin sulphate proteoglycan regulates cell spreading
RT   through Cdc42, Ack-1 and p130cas.";
RL   Nat. Cell Biol. 1:507-513(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=11278436; DOI=10.1074/jbc.M008795200;
RA   Teo M., Tan L., Lim L., Manser E.;
RT   "The tyrosine kinase ACK1 associates with clathrin-coated vesicles
RT   through a binding motif shared by arrestin and other adaptors.";
RL   J. Biol. Chem. 276:18392-18398(2001).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-827; TYR-859 AND
RP   TYR-860, AND MASS SPECTROMETRY.
RX   MEDLINE=22426906; PubMed=12522270; DOI=10.1073/pnas.2436191100;
RA   Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,
RA   Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.;
RT   "Profiling of tyrosine phosphorylation pathways in human cells using
RT   mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003).
RN   [8]
RP   AUTOPHOSPHORYLATION, INTERACTION WITH HSP90AB1; MTERK AND WWOX, AND
RP   MUTAGENESIS OF LYS-158 AND LEU-487.
RX   PubMed=16288044; DOI=10.1158/0008-5472.CAN-05-1127;
RA   Mahajan N.P., Whang Y.E., Mohler J.L., Earp H.S.;
RT   "Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role
RT   of Ack1 in polyubiquitination of tumor suppressor Wwox.";
RL   Cancer Res. 65:10514-10523(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-284; TYR-518; TYR-859
RP   AND TYR-860, AND MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [10]
RP   INTERACTION WITH AR.
RX   PubMed=17494760; DOI=10.1073/pnas.0700420104;
RA   Mahajan N.P., Liu Y., Majumder S., Warren M.R., Parker C.E.,
RA   Mohler J.L., Earp H.S., Whang Y.E.;
RT   "Activated Cdc42-associated kinase Ack1 promotes prostate cancer
RT   progression via androgen receptor tyrosine phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:8438-8443(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-859 AND TYR-860, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-518, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149 AND TYR-827, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION, AND AUTOPHOSPHORYLATION AT TYR-284.
RX   PubMed=16472662; DOI=10.1016/S0076-6879(06)06018-6;
RA   Yokoyama N., Miller W.T.;
RT   "Purification and enzyme activity of ACK1.";
RL   Methods Enzymol. 406:250-260(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-518 AND TYR-859, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [16]
RP   INTERACTION WITH UBA.
RX   PubMed=17182860; DOI=10.1091/mbc.E06-02-0142;
RA   Shen F., Lin Q., Gu Y., Childress C., Yang W.;
RT   "Activated Cdc42-associated kinase 1 is a component of EGF receptor
RT   signaling complex and regulates EGF receptor degradation.";
RL   Mol. Biol. Cell 18:732-742(2007).
RN   [17]
RP   INTERACTION WITH NPHP1.
RX   PubMed=18477472; DOI=10.1016/j.bbrc.2008.05.016;
RA   Eley L., Moochhala S.H., Simms R., Hildebrandt F., Sayer J.A.;
RT   "Nephrocystin-1 interacts directly with Ack1 and is expressed in human
RT   collecting duct.";
RL   Biochem. Biophys. Res. Commun. 371:877-882(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-101; SER-785 AND
RP   SER-881, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-860, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-101; TYR-284; THR-517;
RP   TYR-518; SER-724; SER-728; SER-785; TYR-827 AND THR-925, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   STRUCTURE BY NMR OF 448-489.
RX   MEDLINE=99287324; PubMed=10360579; DOI=10.1038/20732;
RA   Mott H.R., Owen D., Nietlispach D., Lowe P.N., Manser E., Lim L.,
RA   Laue E.D.;
RT   "Structure of the small G protein Cdc42 bound to the GTPase-binding
RT   domain of ACK.";
RL   Nature 399:384-388(1999).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 107-395, AND PHOSPHORYLATION
RP   AT TYR-284.
RX   PubMed=15308621; DOI=10.1074/jbc.M406703200;
RA   Lougheed J.C., Chen R.-H., Mak P., Stout T.J.;
RT   "Crystal structures of the phosphorylated and unphosphorylated kinase
RT   domains of the Cdc42-associated tyrosine kinase ACK1.";
RL   J. Biol. Chem. 279:44039-44045(2004).
RN   [23]
RP   VARIANTS LEU-34; ARG-71; GLN-99; TRP-99; MET-152; LYS-346; ILE-409;
RP   SER-507; LEU-725; GLN-748 AND HIS-1038.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Downstream effector of CDC42 which mediates CDC42-
CC       dependent cell migration via phosphorylation of BCAR1. Binds to
CC       both poly- and mono-ubiquitin and regulates ligand-induced
CC       degradation of EGFR. Participates in clathrin-mediated
CC       endocytosis. May be involved both in adult synaptic function and
CC       plasticity and in brain development.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: The SH3 domain appears to play an
CC       autoinhibitory role (By similarity).
CC   -!- SUBUNIT: Interacts with CDC42. Interacts with activated CSPG4.
CC       Interacts with AR. Interacts with WWOX. Interacts with MERTK
CC       (activated); stimulates autophosphorylation. May interact
CC       (phosphorylated) with HSP90AB1; maintains kinase activity.
CC       Interacts with NPHP1.
CC   -!- INTERACTION:
CC       P60953:CDC42; NbExp=1; IntAct=EBI-603457, EBI-81752;
CC       Q05209:PTPN12; NbExp=1; IntAct=EBI-603457, EBI-2266035;
CC       P08575:PTPRC; NbExp=1; IntAct=EBI-603457, EBI-1341;
CC       Q12913:PTPRJ; NbExp=1; IntAct=EBI-603457, EBI-2264500;
CC   -!- SUBCELLULAR LOCATION: Cell membrane (By similarity). Cell
CC       junction, adherens junction (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q07912-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q07912-2; Sequence=VSP_008655, VSP_008656;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay;
CC       Name=3;
CC         IsoId=Q07912-3; Sequence=VSP_037284, VSP_037285, VSP_037286;
CC         Note=No experimental confirmation available;
CC   -!- PTM: Autophosphorylation regulates kinase activity.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH08884.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites;
CC   -!- WEB RESOURCE: Name=CGP resequencing studies;
CC       URL="http://www.sanger.ac.uk/perl/genetics/CGP/cgp_viewer?action=gene&ln=ACK1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13738; AAA53570.2; -; mRNA.
DR   EMBL; AK131539; BAD18675.1; -; mRNA.
DR   EMBL; AC124944; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008884; AAH08884.1; ALT_SEQ; mRNA.
DR   EMBL; BC028164; AAH28164.1; -; mRNA.
DR   IPI; IPI00167089; -.
DR   IPI; IPI00442025; -.
DR   IPI; IPI00552750; -.
DR   PIR; S33596; S33596.
DR   RefSeq; NP_001010938.1; -.
DR   RefSeq; NP_005772.3; -.
DR   UniGene; Hs.518513; -.
DR   PDB; 1CF4; NMR; -; B=448-489.
DR   PDB; 1U46; X-ray; 2.00 A; A/B=109-395.
DR   PDB; 1U4D; X-ray; 2.10 A; A/B=109-395.
DR   PDB; 1U54; X-ray; 2.80 A; A/B=109-395.
DR   PDB; 3EQP; X-ray; 2.30 A; A/B=117-392.
DR   PDB; 3EQR; X-ray; 2.00 A; A/B=117-392.
DR   PDBsum; 1CF4; -.
DR   PDBsum; 1U46; -.
DR   PDBsum; 1U4D; -.
DR   PDBsum; 1U54; -.
DR   PDBsum; 3EQP; -.
DR   PDBsum; 3EQR; -.
DR   ProteinModelPortal; Q07912; -.
DR   IntAct; Q07912; 23.
DR   STRING; Q07912; -.
DR   PhosphoSite; Q07912; -.
DR   PRIDE; Q07912; -.
DR   Ensembl; ENST00000333602; ENSP00000329425; ENSG00000061938.
DR   Ensembl; ENST00000392400; ENSP00000376201; ENSG00000061938.
DR   Ensembl; ENST00000414741; ENSP00000413373; ENSG00000061938.
DR   GeneID; 10188; -.
DR   KEGG; hsa:10188; -.
DR   UCSC; uc003fvs.1; human.
DR   UCSC; uc003fvu.1; human.
DR   CTD; 10188; -.
DR   GeneCards; GC03M195590; -.
DR   H-InvDB; HIX0003961; -.
DR   HGNC; HGNC:19297; TNK2.
DR   HPA; CAB009948; -.
DR   MIM; 606994; gene.
DR   PharmGKB; PA134888760; -.
DR   eggNOG; prNOG06071; -.
DR   HOVERGEN; HBG100429; -.
DR   OMA; PRVPPRE; -.
DR   PhylomeDB; Q07912; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BindingDB; Q07912; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   NextBio; 38556; -.
DR   ArrayExpress; Q07912; -.
DR   Bgee; Q07912; -.
DR   CleanEx; HS_TNK2; -.
DR   Genevestigator; Q07912; -.
DR   GermOnline; ENSG00000061938; Homo sapiens.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine ph...; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc.
DR   InterPro; IPR015116; GTPase_binding.
DR   InterPro; IPR021619; Inhibitor_Mig-6.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR015779; Tyr_kinase_non-rcpt_Ack_N.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   PANTHER; PTHR23256:SF265; ACK_tyr_kin_N; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF09027; GTPase_binding; 1.
DR   Pfam; PF11555; Inhibitor_Mig-6; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS50108; CRIB; FALSE_NEG.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell junction;
KW   Cell membrane; Complete proteome; Kinase; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   SH3 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1   1038       Activated CDC42 kinase 1.
FT                                /FTId=PRO_0000088058.
FT   DOMAIN      126    385       Protein kinase.
FT   DOMAIN      386    448       SH3.
FT   DOMAIN      454    466       CRIB.
FT   NP_BIND     132    140       ATP.
FT   COMPBIAS    577    958       Pro-rich.
FT   ACT_SITE    252    252       Proton acceptor.
FT   BINDING     158    158       ATP.
FT   MOD_RES     101    101       Phosphothreonine.
FT   MOD_RES     149    149       Phosphoserine.
FT   MOD_RES     284    284       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     517    517       Phosphothreonine.
FT   MOD_RES     518    518       Phosphotyrosine.
FT   MOD_RES     724    724       Phosphoserine.
FT   MOD_RES     728    728       Phosphoserine.
FT   MOD_RES     785    785       Phosphoserine.
FT   MOD_RES     827    827       Phosphotyrosine.
FT   MOD_RES     859    859       Phosphotyrosine.
FT   MOD_RES     860    860       Phosphotyrosine.
FT   MOD_RES     881    881       Phosphoserine.
FT   MOD_RES     925    925       Phosphothreonine.
FT   VAR_SEQ       1      1       M -> MLEARPPRTQGSDAAGAAAGRGLRALLLSLTAAAGI
FT                                WGSMGERSAYQRLAGGEEGPQRLGGGRM (in isoform
FT                                3).
FT                                /FTId=VSP_037284.
FT   VAR_SEQ     485    528       LYLGNPMDPPDLLSVELSTSRPPQHLGGVKKPTYDPVSEDQ
FT                                DPL -> CPFSAFSPGHPPAETCGQVLWTGRREACASDPRL
FT                                HPVSSRTKGL (in isoform 2).
FT                                /FTId=VSP_008655.
FT   VAR_SEQ     514    514       K -> KREPPPRPPQPAFFTQ (in isoform 3).
FT                                /FTId=VSP_037285.
FT   VAR_SEQ     529   1038       Missing (in isoform 2).
FT                                /FTId=VSP_008656.
FT   VAR_SEQ     965    994       Missing (in isoform 3).
FT                                /FTId=VSP_037286.
FT   VARIANT      34     34       R -> L (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_032792.
FT   VARIANT      71     71       K -> R (in dbSNP:rs56036945).
FT                                /FTId=VAR_032793.
FT   VARIANT      99     99       R -> Q (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_032794.
FT   VARIANT      99     99       R -> W (in dbSNP:rs3747673).
FT                                /FTId=VAR_032795.
FT   VARIANT     152    152       T -> M (in dbSNP:rs56161912).
FT                                /FTId=VAR_032796.
FT   VARIANT     346    346       E -> K (in an ovarian endometrioid cancer
FT                                sample; somatic mutation).
FT                                /FTId=VAR_032797.
FT   VARIANT     409    409       M -> I (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_032798.
FT   VARIANT     507    507       P -> S (in dbSNP:rs35759128).
FT                                /FTId=VAR_032799.
FT   VARIANT     725    725       P -> L (in dbSNP:rs56260729).
FT                                /FTId=VAR_032800.
FT   VARIANT     748    748       R -> Q (in dbSNP:rs57872314).
FT                                /FTId=VAR_032801.
FT   VARIANT     802    802       P -> L (in dbSNP:rs3749333).
FT                                /FTId=VAR_057115.
FT   VARIANT    1038   1038       R -> H (in dbSNP:rs13433937).
FT                                /FTId=VAR_032802.
FT   MUTAGEN     158    158       K->R: Loss of autophosphorylation.
FT   MUTAGEN     487    487       L->F: Constantly active kinase.
FT   CONFLICT    138    138       G -> V (in Ref. 4; AAH08884).
FT   CONFLICT    304    352       TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID
FT                                KEGERLPR -> PPWRDISASSSTQFPHAVPCFPTSLLAKL
FT                                LLRHSVPASSREIKLVSILC (in Ref. 4;
FT                                AAH08884).
FT   CONFLICT    353   1038       Missing (in Ref. 4; AAH08884).
FT   CONFLICT    586    586       A -> P (in Ref. 1; AAA53570).
FT   CONFLICT    722    722       Missing (in Ref. 1; AAA53570).
FT   CONFLICT    838    840       PRA -> AG (in Ref. 1; AAA53570).
FT   HELIX       123    125
FT   STRAND      126    133
FT   STRAND      140    146
FT   STRAND      152    158
FT   HELIX       169    183
FT   STRAND      192    196
FT   STRAND      198    200
FT   STRAND      202    206
FT   HELIX       213    220
FT   HELIX       221    223
FT   HELIX       226    245
FT   HELIX       255    257
FT   STRAND      258    262
FT   STRAND      265    268
FT   STRAND      283    285
FT   HELIX       294    296
FT   HELIX       299    304
FT   STRAND      306    308
FT   HELIX       309    324
FT   TURN        330    333
FT   HELIX       336    344
FT   HELIX       358    367
FT   HELIX       372    374
FT   HELIX       378    388
SQ   SEQUENCE   1038 AA;  114569 MW;  74A1980665BC3E6B CRC64;
     MQPEEGTGWL LELLSEVQLQ QYFLRLRDDL NVTRLSHFEY VKNEDLEKIG MGRPGQRRLW
     EAVKRRKALC KRKSWMSKVF SGKRLEAEFP PHHSQSTFRK TSPAPGGPAG EGPLQSLTCL
     IGEKDLRLLE KLGDGSFGVV RRGEWDAPSG KTVSVAVKCL KPDVLSQPEA MDDFIREVNA
     MHSLDHRNLI RLYGVVLTPP MKMVTELAPL GSLLDRLRKH QGHFLLGTLS RYAVQVAEGM
     GYLESKRFIH RDLAARNLLL ATRDLVKIGD FGLMRALPQN DDHYVMQEHR KVPFAWCAPE
     SLKTRTFSHA SDTWMFGVTL WEMFTYGQEP WIGLNGSQIL HKIDKEGERL PRPEDCPQDI
     YNVMVQCWAH KPEDRPTFVA LRDFLLEAQP TDMRALQDFE EPDKLHIQMN DVITVIEGRA
     ENYWWRGQNT RTLCVGPFPR NVVTSVAGLS AQDISQPLQN SFIHTGHGDS DPRHCWGFPD
     RIDELYLGNP MDPPDLLSVE LSTSRPPQHL GGVKKPTYDP VSEDQDPLSS DFKRLGLRKP
     GLPRGLWLAK PSARVPGTKA SRGSGAEVTL IDFGEEPVVP ALRPCAPSLA QLAMDACSLL
     DETPPQSPTR ALPRPLHPTP VVDWDARPLP PPPAYDDVAQ DEDDFEICSI NSTLVGAGVP
     AGPSQGQTNY AFVPEQARPP PPLEDNLFLP PQGGGKPPSS AQTAEIFQAL QQECMRQLQA
     PAGSPAPSPS PGGDDKPQVP PRVPIPPRPT RPHVQLSPAP PGEEETSQWP GPASPPRVPP
     REPLSPQGSR TPSPLVPPGS SPLPPRLSSS PGKTMPTTQS FASDPKYATP QVIQAPGPRA
     GPCILPIVRD GKKVSSTHYY LLPERPSYLE RYQRFLREAQ SPEEPTPLPV PLLLPPPSTP
     APAAPTATVR PMPQAALDPK ANFSTNNSNP GARPPPPRAT ARLPQRGCPG DGPEAGRPAD
     KIQMAMVHGV TTEECQAALQ CHGWSVQRAA QYLKVEQLFG LGLRPRGECH KVLEMFDWNL
     EQAGCHLLGS WGPAHHKR
//
